Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
Each company listed discloses THC in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named THC in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Saum Sutaria | $1,500,000 | $0 | $31,677,365 | $0 | $9,000,000 | $0 | $931,603 | $43,108,969 |
| Chairman and Chief Executive Officer | ||||||||
| Thomas Arnst | 650,000 | 4,000,000 | 3,740,183 | 0 | 1,462,500 | 0 | 196,920 | 10,049,603 |
| Executive Vice President, Chief Administrative Officer, General Counsel and Corporate Secretary | ||||||||
| Lisa Foo | 650,000 | 4,000,000 | 3,382,855 | 0 | 1,316,250 | 0 | 193,709 | 9,542,814 |
| Executive Vice President and Chief Operating Officer | ||||||||
| Sun Park | 700,000 | 2,000,000 | 2,722,562 | 0 | 1,750,000 | 0 | 201,546 | 7,374,108 |
| Executive Vice President and Chief Financial Officer | ||||||||
| Paola Arbour | 550,000 | 1,000,000 | 1,393,533 | 0 | 1,031,250 | 0 | 121,391 | 4,096,174 |
| Executive Vice President and Chief Information Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Saum Sutaria | $43,108,969 | — | — | — |
| Thomas Arnst | 10,049,603 | — | — | — |
| Lisa Foo | 9,542,814 | — | — | — |
| Sun Park | 7,374,108 | — | — | — |
| Paola Arbour | 4,096,174 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Vineeta Agarwala | Director | 2026-05-22 | D | 1,333 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Tammy Romo | Director | 2026-05-22 | A | 1,333 | — | — | Common | Form 4 ↗ |
| Tammy Romo | Director | 2026-05-22 | D | 493 | 174 | 85,674 | Common | Form 4 ↗ |
| Meghan M. FitzGerald | Director | 2026-05-22 | D | 493 | 174 | 85,674 | Common | Form 4 ↗ |
| Cecil D. Haney | Director | 2026-05-22 | D | 493 | 174 | 85,674 | Common | Form 4 ↗ |
| Cecil D. Haney | Director | 2026-05-22 | D | 1,333 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Richard J. Mark | Director | 2026-05-22 | D | 493 | 174 | 85,674 | Common | Form 4 ↗ |
| Richard J. Mark | Director | 2026-05-22 | D | 1,333 | — | — | Derivative, Class A Common | Form 4 ↗ |
| J. Robert Kerrey | Director | 2026-05-22 | A | 1,643 | — | — | Common | Form 4 ↗ |
| J. Robert Kerrey | Director | 2026-05-22 | D | 1,643 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Roy Blunt | Director | 2026-05-22 | A | 1,333 | — | — | Common | Form 4 ↗ |
| Roy Blunt | Director | 2026-05-22 | D | 493 | 174 | 85,674 | Common | Form 4 ↗ |
| Roy Blunt | Director | 2026-05-22 | D | 1,333 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Christopher S. Lynch | Director | 2026-05-22 | A | 1,333 | — | — | Common | Form 4 ↗ |
| Nadja Y. West | Director | 2026-05-22 | A | 1,333 | — | — | Common | Form 4 ↗ |
| Nadja Y. West | Director | 2026-05-22 | D | 1,333 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Richard W. Fisher | Director | 2026-05-22 | D | 1,333 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Meghan M. FitzGerald | Director | 2026-05-22 | A | 1,333 | — | — | Common | Form 4 ↗ |
| Vineeta Agarwala | Director | 2026-05-22 | A | 1,333 | — | — | Common | Form 4 ↗ |
| Cecil D. Haney | Director | 2026-05-22 | A | 1,333 | — | — | Common | Form 4 ↗ |
| Nadja Y. West | Director | 2026-05-22 | D | 493 | 174 | 85,674 | Common | Form 4 ↗ |
| Meghan M. FitzGerald | Director | 2026-05-22 | D | 1,333 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Tammy Romo | Director | 2026-05-22 | D | 1,333 | — | — | Derivative, Class A Common | Form 4 ↗ |
| J. Robert Kerrey | Director | 2026-05-22 | D | 607 | 174 | 105,484 | Common | Form 4 ↗ |
| Richard W. Fisher | Director | 2026-05-22 | A | 1,333 | — | — | Common | Form 4 ↗ |
| Richard W. Fisher | Director | 2026-05-22 | D | 493 | 174 | 85,674 | Common | Form 4 ↗ |
| Richard J. Mark | Director | 2026-05-22 | A | 1,333 | — | — | Common | Form 4 ↗ |
| James L. Bierman | Director | 2026-05-22 | A | 1,333 | — | — | Common | Form 4 ↗ |
| James L. Bierman | Director | 2026-05-22 | D | 1,333 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Christopher S. Lynch | Director | 2026-05-22 | D | 1,333 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-05-27 | — | 13,344 | — | — | 11 insiders, 11 accrual rows | ||
| Nadja Y. West | Director | 2026-05-27 | D | 3,000 | 177 | 532,050 | Common | Form 4 ↗ |
| J. Robert Kerrey | Director | 2026-05-28 | D | 1,690 | 174 | 294,009 | Common | Form 4 ↗ |
| J. Robert Kerrey | Director | 2026-05-28 | D | 713 | 175 | 124,868 | Common | Form 4 ↗ |
| J. Robert Kerrey | Director | 2026-05-28 | D | 905 | 177 | 160,085 | Common | Form 4 ↗ |
| J. Robert Kerrey | Director | 2026-05-28 | D | 361 | 178 | 64,085 | Common | Form 4 ↗ |
| J. Robert Kerrey | Director | 2026-05-28 | D | 1,969 | 173 | 340,873 | Common | Form 4 ↗ |
| James L. Bierman | Director | 2026-07-27 | D | 5,000 | 245 | 1,224,800 | Common | Form 4 ↗ |
| Paola Arbour | EVP, Chief Information Officer | 2026-07-27 | D | 10,878 | 244 | 2,653,144 | Common | Form 4 ↗ |
| Christopher S. Lynch | Director | 2026-07-27 | D | 3,837 | 243 | 934,079 | Common | Form 4 ↗ |
| Lisa Foo | EVP, Chief Operating Officer | 2026-07-29 | D | 10,000 | 258 | 2,580,300 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Vineeta Agarwala | Director | 2026-05-22 | D | 1,333 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Tammy Romo | Director | 2026-05-22 | A | 1,333 | — | — | Common | Form 4 ↗ |
| Tammy Romo | Director | 2026-05-22 | D | 493 | 174 | 85,674 | Common | Form 4 ↗ |
| Meghan M. FitzGerald | Director | 2026-05-22 | D | 493 | 174 | 85,674 | Common | Form 4 ↗ |
| Cecil D. Haney | Director | 2026-05-22 | D | 493 | 174 | 85,674 | Common | Form 4 ↗ |
| Cecil D. Haney | Director | 2026-05-22 | D | 1,333 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Richard J. Mark | Director | 2026-05-22 | D | 493 | 174 | 85,674 | Common | Form 4 ↗ |
| Richard J. Mark | Director | 2026-05-22 | D | 1,333 | — | — | Derivative, Class A Common | Form 4 ↗ |
| J. Robert Kerrey | Director | 2026-05-22 | A | 1,643 | — | — | Common | Form 4 ↗ |
| J. Robert Kerrey | Director | 2026-05-22 | D | 1,643 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Roy Blunt | Director | 2026-05-22 | A | 1,333 | — | — | Common | Form 4 ↗ |
| Roy Blunt | Director | 2026-05-22 | D | 493 | 174 | 85,674 | Common | Form 4 ↗ |
| Roy Blunt | Director | 2026-05-22 | D | 1,333 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Christopher S. Lynch | Director | 2026-05-22 | A | 1,333 | — | — | Common | Form 4 ↗ |
| Nadja Y. West | Director | 2026-05-22 | A | 1,333 | — | — | Common | Form 4 ↗ |
| Nadja Y. West | Director | 2026-05-22 | D | 1,333 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Richard W. Fisher | Director | 2026-05-22 | D | 1,333 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Meghan M. FitzGerald | Director | 2026-05-22 | A | 1,333 | — | — | Common | Form 4 ↗ |
| Vineeta Agarwala | Director | 2026-05-22 | A | 1,333 | — | — | Common | Form 4 ↗ |
| Cecil D. Haney | Director | 2026-05-22 | A | 1,333 | — | — | Common | Form 4 ↗ |
| Nadja Y. West | Director | 2026-05-22 | D | 493 | 174 | 85,674 | Common | Form 4 ↗ |
| Meghan M. FitzGerald | Director | 2026-05-22 | D | 1,333 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Tammy Romo | Director | 2026-05-22 | D | 1,333 | — | — | Derivative, Class A Common | Form 4 ↗ |
| J. Robert Kerrey | Director | 2026-05-22 | D | 607 | 174 | 105,484 | Common | Form 4 ↗ |
| Richard W. Fisher | Director | 2026-05-22 | A | 1,333 | — | — | Common | Form 4 ↗ |
| Richard W. Fisher | Director | 2026-05-22 | D | 493 | 174 | 85,674 | Common | Form 4 ↗ |
| Richard J. Mark | Director | 2026-05-22 | A | 1,333 | — | — | Common | Form 4 ↗ |
| James L. Bierman | Director | 2026-05-22 | A | 1,333 | — | — | Common | Form 4 ↗ |
| James L. Bierman | Director | 2026-05-22 | D | 1,333 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Christopher S. Lynch | Director | 2026-05-22 | D | 1,333 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Vineeta Agarwala | Director | 2026-05-27 | A | 1,188 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Richard W. Fisher | Director | 2026-05-27 | A | 1,188 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Cecil D. Haney | Director | 2026-05-27 | A | 1,188 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Richard J. Mark | Director | 2026-05-27 | A | 1,188 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Tammy Romo | Director | 2026-05-27 | A | 1,188 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| James L. Bierman | Director | 2026-05-27 | A | 1,188 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| J. Robert Kerrey | Director | 2026-05-27 | A | 1,464 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Christopher S. Lynch | Director | 2026-05-27 | A | 1,188 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Nadja Y. West | Director | 2026-05-27 | A | 1,188 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Meghan M. FitzGerald | Director | 2026-05-27 | A | 1,188 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Nadja Y. West | Director | 2026-05-27 | D | 3,000 | 177 | 532,050 | Common | Form 4 ↗ |
| Roy Blunt | Director | 2026-05-27 | A | 1,188 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| J. Robert Kerrey | Director | 2026-05-28 | D | 1,690 | 174 | 294,009 | Common | Form 4 ↗ |
| J. Robert Kerrey | Director | 2026-05-28 | D | 713 | 175 | 124,868 | Common | Form 4 ↗ |
| J. Robert Kerrey | Director | 2026-05-28 | D | 905 | 177 | 160,085 | Common | Form 4 ↗ |
| J. Robert Kerrey | Director | 2026-05-28 | D | 361 | 178 | 64,085 | Common | Form 4 ↗ |
| J. Robert Kerrey | Director | 2026-05-28 | D | 1,969 | 173 | 340,873 | Common | Form 4 ↗ |
| James L. Bierman | Director | 2026-07-27 | D | 5,000 | 245 | 1,224,800 | Common | Form 4 ↗ |
| Paola Arbour | EVP, Chief Information Officer | 2026-07-27 | D | 10,878 | 244 | 2,653,144 | Common | Form 4 ↗ |
| Christopher S. Lynch | Director | 2026-07-27 | D | 3,837 | 243 | 934,079 | Common | Form 4 ↗ |
| Lisa Foo | EVP, Chief Operating Officer | 2026-07-29 | D | 10,000 | 258 | 2,580,300 | Common | Form 4 ↗ |
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Sun Park | PSU | — | — | 4,670 | — | 11,675 | $686,677 |
| Paola Arbour | PSU | — | — | 2,799 | — | 6,298 | 440,143 |
| Saum Sutaria | PSU | — | — | 36,384 | — | 81,864 | 5,721,384 |
| Lisa Foo | PSU | — | — | 4,199 | — | 9,448 | 660,293 |
| Thomas Arnst | PSU | — | — | 5,598 | — | 12,596 | 880,286 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Sun Park | $0 | $686,677 | $0 | 100.0% |
| Paola Arbour | 0 | 440,143 | 0 | 100.0% |
| Saum Sutaria | 0 | 5,721,384 | 0 | 100.0% |
| Lisa Foo | 0 | 660,293 | 0 | 100.0% |
| Thomas Arnst | 0 | 880,286 | 0 | 100.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Paola Arbour | PSU | 3,168 | — | $629,545 |
| Sutaria | RSU | 39,049 | — | 7,759,817 |
| Sun Park | PSU | 23,350 | — | 4,640,112 |
| Paola Arbour | RSU | 3,737 | — | 742,617 |
| Paola Arbour | RSU | 3,801 | — | 755,335 |
| Sutaria | RSU | 245,592 | — | 48,804,042 |
| Sutaria | RSU | 54,728 | — | 10,875,548 |
| Sutaria | PSU | 48,810 | — | 9,699,523 |
| Thomas Arnst | RSU | 37,786 | — | 7,508,834 |
| Sutaria | RSU | 36,384 | — | 7,230,228 |
| Lisa Foo | RSU | 28,340 | — | 5,631,725 |
| Thomas Arnst | PSU | 28,020 | — | 5,568,134 |
| Lisa Foo | PSU | 23,250 | — | 4,640,112 |
| Paola Arbour | RSU | 18,894 | — | 3,754,616 |
| Thomas Arnst | RSU | 11,209 | — | 2,227,452 |
| Paola Arbour | PSU | 9,340 | — | 1,856,045 |
| Thomas Arnst | RSU | 5,598 | — | 1,112,435 |
| Sutaria | PSU | 68,410 | — | 13,594,435 |
| Sutaria | RSU | 44,834 | — | 8,909,412 |
| Lisa Foo | RSU | 4,199 | — | 834,425 |
| Sutaria | PSU | 168,125 | — | 33,409,800 |
| Paola Arbour | RSU | 2,799 | — | 556,217 |
| Lisa Foo | RSU | 11,402 | — | 2,265,805 |
| Sun Park | RSU | 11,402 | — | 2,265,805 |
| Thomas Arnst | RSU | 11,402 | — | 2,265,805 |
| Sun Park | PSU | 9,500 | — | 1,887,840 |
| Lisa Foo | RSU | 9,341 | — | 1,856,244 |
| Thomas Arnst | PSU | 9,500 | — | 1,887,840 |
| Lisa Foo | PSU | 9,500 | — | 1,887,840 |
We maintain the following best practices so that our governance of executive compensation reflects our pay-for-performance philosophy and aligns the interests of our executives and shareholders.
| CEO STI target (% of salary) | 200% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Meridian Compensation Partners, LLC |
| Clawback policy | True |
| Anti-hedging | True |
| Anti-pledging | True |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-05-27 | 62,554,346 | 11,817,273 | 39,895 | 84.11% | Passed |
| 2025 | 2025-05-22 | 72,929,010 | 5,362,708 | 54,604 | 93.15% | Passed |
| 2024 | 2024-05-22 | 78,324,154 | 2,920,906 | 147,662 | 96.4% | Passed |
| 2023 | 2023-05-25 | 81,530,105 | 4,617,910 | 429,727 | 94.64% | Passed |
| 2022 | 2022-05-06 | 85,140,056 | 2,843,356 | 59,908 | 96.7% | Passed |
| 2021 | 2021-05-06 | 87,297,266 | 4,828,993 | 113,698 | 94.76% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2026 | 2026-05-27 | 84.11%a |
| 2025 | 2025-05-22 | 93.15%b |
| 2024 | 2024-05-22 | 96.4%c |
a. Approved under the standard stated in the filing — “84 Table of Contents General Information Regarding the Annual Meeting and Voting • The following items of business will be approved if the votes cast for the proposal exceed those cast against the proposal, with neither abstentions nor broker non-votes counted either for or against these proposals (and therefore having no effect on the approval of the proposals): • advisory approval of the Company's executive compensation (Proposal 2);”.
b. Approved under the standard stated in the filing — “• The following items of business will be approved if the votes cast for the proposal exceed those cast against the proposal, with neither abstentions nor broker non-votes counted either for or against these proposals (and therefore having no effect on the approval of the proposals): • advisory approval of the Company's executive compensation (Proposal 2);”.
c. Approved under the standard stated in the filing — “• The following items of business will be approved if the votes cast for the proposal exceed those cast against the proposal, with neither abstentions nor broker non-votes counted either for or against these proposals (and therefore having no effect on the approval of the proposals): • advisory approval of the Company's executive compensation (Proposal 2);”.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Ratio (CEO : median employee) | 711 : 1 |
|---|---|
| CEO total compensation | $43,108,969 |
| Median employee compensation | $60,657 |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Stephen H. RusckowskiIndependent · Departed during FY | $145,000 | $470,936 | $0 | $0 | — | $615,936 |
| J. Robert KerreyIndependent · Lead Independent Director · Human Resources (Chair) · Quality, Compliance & Ethics | 313,000 | 265,065 | 0 | 0 | — | 578,065 |
| Tammy RomoIndependent · Audit (Chair) · Human Resources | 180,000 | 215,053 | 0 | 0 | — | 395,053 |
| Cecil D. HaneyIndependent · Audit | 151,000 | 215,053 | 0 | 0 | 25,000 | 391,053 |
| Richard W. FisherIndependent · Audit · Human Resources | 168,500 | 215,053 | 0 | 0 | — | 383,553 |
| Meghan M. FitzGeraldIndependent · Nominating and Corporate Governance (Chair) | 160,500 | 215,053 | 0 | 0 | — | 375,553 |
| James L. BiermanIndependent · Nominating and Corporate Governance · Quality, Compliance & Ethics (Chair) | 160,500 | 215,053 | 0 | 0 | — | 375,553 |
| Richard J. MarkIndependent · Audit · Human Resources | 157,000 | 215,053 | 0 | 0 | — | 372,053 |
| Christopher S. LynchIndependent · Audit · Human Resources | 155,000 | 215,053 | 0 | 0 | — | 370,053 |
| Roy BluntIndependent · Audit | 151,000 | 215,053 | 0 | 0 | — | 366,053 |
| Vineeta AgarwalaIndependent · Human Resources · Quality, Compliance & Ethics | 147,000 | 215,053 | 0 | 0 | — | 362,053 |
| Nadja Y. WestIndependent · Nominating and Corporate Governance | 145,000 | 215,053 | 0 | 0 | — | 360,053 |
| Saumya SutariaEmployee director · Board Chair | 0 | 0 | 0 | — | 0 | 0 |
| Annual cash retainer | $125,000 |
|---|---|
| Annual equity retainer | $215,053 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | — |
| Stock ownership guideline | — |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $2,033,500 |
| Equity awards (grant-date value) | $2,886,531 |
| All other compensation | $25,000 |
| Total cost of the board | $4,945,031 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Of the companies Tenet HealthCare names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including Tenet HealthCare.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Tenet HealthCare | 2025 | Saum Sutaria | $1,500,000 | $31,677,365 | $0 | $9,000,000 | $43,108,969 |
| 2 | Baxter International | 2025 | Andrew Hider | 499,315 | 23,133,518 | 3,185,053 | 820,125 | 29,805,182 |
| 3 | HCA Healthcare | 2025 | Samuel Hazen | 1,577,815 | 8,474,543 | 8,514,090 | 5,416,732 | 26,456,606 |
| 4 | Stryker | 2025 | Kevin Lobo | 1,500,000 | 16,684,917 | 0 | 2,250,000 | 21,401,495 |
| 5 | Humana | 2025 | James Rechtin | 1,348,558 | 13,868,141 | 0 | 3,034,740 | 18,757,075 |
| 6 | DaVita | 2025 | Javier Rodriguez | 1,500,000 | 11,442,481 | 2,699,982 | 2,089,491 | 18,210,597 |
| 7 | Becton, Dickinson and Company | 2025 | Thomas Polen | 1,395,463 | 9,991,854 | 3,311,861 | 1,852,010 | 17,129,140 |
| 8 | Universal Health Services | 2025 | Marc Miller | 1,430,769 | 9,999,904 | 0 | 4,292,307 | 16,148,937 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Tenet HealthCare | 200% | PSU 60 · RSU 40 | No | Meridian Compensation Partners, LLC |
| Baxter International | not disclosed | PSU 50 · Stock Options 25 · RSU 25 | not disclosed | Aon |
| Becton, Dickinson and Company | 85% | PSU 50 · Options 25 · RSU 25 | No | Semler Brossy |
| DaVita | 93% | PSU 60 · RSU 20 · Options 20 | Yes — Relative TSR v. S&P Health Care Services Select Industry Index | Compensia |
| HCA Healthcare | 195.78% | SAR 50 · PSU 50 | No | Semler Brossy |
| Humana | 112% | PSU 60 · RSU 40 | Yes — Relative TSR | Farient Advisors, LLC |
| Stryker | 100% | PSU 48 · Options 34 | No | Semler Brossy |
| Universal Health Services | 200% | RSU 50 · PSU 50 | No | FW Cook |
Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Saum Sutaria | DEF 14A | 2026-04-16 | 0001193125-26-159118 | Section “2025 Summary Compensation Table” · page 61. As printed: 43,108,969. Filing ↗machine: r4 · c34 · span 969343–969353 |
| 2 | Section 01, Thomas Arnst | DEF 14A | 2026-04-16 | 0001193125-26-159118 | Section “2025 Summary Compensation Table” · page 61. As printed: 10,049,603. Filing ↗machine: r11 · c34 · span 986214–986224 |
| 3 | Section 01, Lisa Foo | DEF 14A | 2026-04-16 | 0001193125-26-159118 | Section “2025 Summary Compensation Table” · page 61. As printed: 9,542,814. Filing ↗machine: r15 · c34 · span 996000–996009 |
| 4 | Section 01, Sun Park | DEF 14A | 2026-04-16 | 0001193125-26-159118 | Section “2025 Summary Compensation Table” · page 61. As printed: 7,374,108. Filing ↗machine: r8 · c34 · span 978591–978600 |
| 5 | Section 01, Paola Arbour | DEF 14A | 2026-04-16 | 0001193125-26-159118 | Section “2025 Summary Compensation Table” · page 61. As printed: 4,096,174. Filing ↗machine: r19 · c34 · span 1005245–1005254 |
| 6 | Section 03, Sun Park PSU | DEF 14A | 2026-04-16 | 0001193125-26-159118 | Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. Filing ↗machine: t352 · r14 · c39 · span 1124649–1124654 |
| 7 | Section 03, Paola Arbour PSU | DEF 14A | 2026-04-16 | 0001193125-26-159118 | Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. Filing ↗machine: t361 · r6 · c9 · span 1299235–1299240 |
| 8 | Section 03, Saum Sutaria PSU | DEF 14A | 2026-04-16 | 0001193125-26-159118 | Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. Filing ↗machine: t359 · r6 · c9 · span 1213082–1213088 |
| 9 | Section 03, Lisa Foo PSU | DEF 14A | 2026-04-16 | 0001193125-26-159118 | Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. Filing ↗machine: t359 · r42 · c9 · span 1272685–1272690 |
| 10 | Section 03, Thomas Arnst PSU | DEF 14A | 2026-04-16 | 0001193125-26-159118 | Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. Filing ↗machine: t359 · r30 · c9 · span 1252788–1252793 |
| 11 | Section 07, pay ratio | DEF 14A | 2026-04-16 | 0001193125-26-159118 | Section “CEO Pay Ratio”. As printed: 711 : 1. Filing ↗ |
| 12 | Section 08, Stephen H. Rusckowski | DEF 14A | 2026-04-16 | 0001193125-26-159118 | Section “Director Compensation”. As printed: 615,936. Filing ↗machine: t258 · r23 · c19 · span 604194–604201 |
| 13 | Section 08, J. Robert Kerrey | DEF 14A | 2026-04-16 | 0001193125-26-159118 | Section “Director Compensation”. As printed: 578,065. Filing ↗machine: t258 · r3 · c19 · span 578716–578723 |
| 14 | Section 08, Tammy Romo | DEF 14A | 2026-04-16 | 0001193125-26-159118 | Section “Director Compensation”. As printed: 395,053. Filing ↗machine: t258 · r21 · c19 · span 601504–601511 |
| 15 | Section 08, Cecil D. Haney | DEF 14A | 2026-04-16 | 0001193125-26-159118 | Section “Director Compensation”. As printed: 391,053. Filing ↗machine: t258 · r15 · c19 · span 593918–593925 |
| 16 | Section 08, Richard W. Fisher | DEF 14A | 2026-04-16 | 0001193125-26-159118 | Section “Director Compensation”. As printed: 383,553. Filing ↗machine: t258 · r11 · c19 · span 588873–588880 |
| 17 | Section 08, Meghan M. FitzGerald | DEF 14A | 2026-04-16 | 0001193125-26-159118 | Section “Director Compensation”. As printed: 375,553. Filing ↗machine: t258 · r13 · c19 · span 591396–591403 |
| 18 | Section 08, James L. Bierman | DEF 14A | 2026-04-16 | 0001193125-26-159118 | Section “Director Compensation”. As printed: 375,553. Filing ↗machine: t258 · r7 · c19 · span 583803–583810 |
| 19 | Section 08, Richard J. Mark | DEF 14A | 2026-04-16 | 0001193125-26-159118 | Section “Director Compensation”. As printed: 372,053. Filing ↗machine: t258 · r19 · c19 · span 598997–599004 |
| 20 | Section 08, Christopher S. Lynch | DEF 14A | 2026-04-16 | 0001193125-26-159118 | Section “Director Compensation”. As printed: 370,053. Filing ↗machine: t258 · r17 · c19 · span 596435–596442 |
| 21 | Section 08, Roy Blunt | DEF 14A | 2026-04-16 | 0001193125-26-159118 | Section “Director Compensation”. As printed: 366,053. Filing ↗machine: t258 · r9 · c19 · span 586309–586316 |
| 22 | Section 08, Vineeta Agarwala | DEF 14A | 2026-04-16 | 0001193125-26-159118 | Section “Director Compensation”. As printed: 362,053. Filing ↗machine: t258 · r5 · c19 · span 581240–581247 |
| 23 | Section 08, Nadja Y. West | DEF 14A | 2026-04-16 | 0001193125-26-159118 | Section “Director Compensation”. As printed: 360,053. Filing ↗machine: t258 · r25 · c19 · span 606710–606717 |
| 24 | Section 08, Saumya Sutaria | DEF 14A | 2026-04-16 | 0001193125-26-159118 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 25 | Section 02, Vineeta Agarwala 2026-05-22 | Form 4 | 2026-05-26 | 0001193125-26-239937 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 26 | Section 02, Tammy Romo 2026-05-22 | Form 4 | 2026-05-26 | 0001193125-26-239940 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 27 | Section 02, Tammy Romo 2026-05-22 | Form 4 | 2026-05-26 | 0001193125-26-239940 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 28 | Section 02, Meghan M. FitzGerald 2026-05-22 | Form 4 | 2026-05-26 | 0001193125-26-239938 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 29 | Section 02, Cecil D. Haney 2026-05-22 | Form 4 | 2026-05-26 | 0001193125-26-239935 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 30 | Section 02, Cecil D. Haney 2026-05-22 | Form 4 | 2026-05-26 | 0001193125-26-239935 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 31 | Section 02, Richard J. Mark 2026-05-22 | Form 4 | 2026-05-26 | 0001193125-26-239936 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 32 | Section 02, Richard J. Mark 2026-05-22 | Form 4 | 2026-05-26 | 0001193125-26-239936 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 33 | Section 02, J. Robert Kerrey 2026-05-22 | Form 4 | 2026-05-26 | 0001193125-26-239934 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 34 | Section 02, J. Robert Kerrey 2026-05-22 | Form 4 | 2026-05-26 | 0001193125-26-239934 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 35 | Section 02, Roy Blunt 2026-05-22 | Form 4 | 2026-05-26 | 0001193125-26-239933 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 36 | Section 02, Roy Blunt 2026-05-22 | Form 4 | 2026-05-26 | 0001193125-26-239933 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 37 | Section 02, Roy Blunt 2026-05-22 | Form 4 | 2026-05-26 | 0001193125-26-239933 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 38 | Section 02, Christopher S. Lynch 2026-05-22 | Form 4 | 2026-05-26 | 0001193125-26-239942 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 39 | Section 02, Nadja Y. West 2026-05-22 | Form 4 | 2026-05-26 | 0001193125-26-239941 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 40 | Section 02, Nadja Y. West 2026-05-22 | Form 4 | 2026-05-26 | 0001193125-26-239941 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 41 | Section 02, Richard W. Fisher 2026-05-22 | Form 4 | 2026-05-26 | 0001193125-26-239939 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 42 | Section 02, Meghan M. FitzGerald 2026-05-22 | Form 4 | 2026-05-26 | 0001193125-26-239938 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 43 | Section 02, Vineeta Agarwala 2026-05-22 | Form 4 | 2026-05-26 | 0001193125-26-239937 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 44 | Section 02, Cecil D. Haney 2026-05-22 | Form 4 | 2026-05-26 | 0001193125-26-239935 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 45 | Section 02, Nadja Y. West 2026-05-22 | Form 4 | 2026-05-26 | 0001193125-26-239941 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 46 | Section 02, Meghan M. FitzGerald 2026-05-22 | Form 4 | 2026-05-26 | 0001193125-26-239938 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 47 | Section 02, Tammy Romo 2026-05-22 | Form 4 | 2026-05-26 | 0001193125-26-239940 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 48 | Section 02, J. Robert Kerrey 2026-05-22 | Form 4 | 2026-05-26 | 0001193125-26-239934 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 49 | Section 02, Richard W. Fisher 2026-05-22 | Form 4 | 2026-05-26 | 0001193125-26-239939 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 50 | Section 02, Richard W. Fisher 2026-05-22 | Form 4 | 2026-05-26 | 0001193125-26-239939 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 51 | Section 02, Richard J. Mark 2026-05-22 | Form 4 | 2026-05-26 | 0001193125-26-239936 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 52 | Section 02, James L. Bierman 2026-05-22 | Form 4 | 2026-05-26 | 0001193125-26-239943 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 53 | Section 02, James L. Bierman 2026-05-22 | Form 4 | 2026-05-26 | 0001193125-26-239943 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 54 | Section 02, Christopher S. Lynch 2026-05-22 | Form 4 | 2026-05-26 | 0001193125-26-239942 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 55 | Section 02, Vineeta Agarwala 2026-05-27 | Form 4 | 2026-05-28 | 0001193125-26-245814 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 56 | Section 02, Richard W. Fisher 2026-05-27 | Form 4 | 2026-05-28 | 0001193125-26-245810 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 57 | Section 02, Cecil D. Haney 2026-05-27 | Form 4 | 2026-05-28 | 0001193125-26-245809 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 58 | Section 02, Richard J. Mark 2026-05-27 | Form 4 | 2026-05-28 | 0001193125-26-245812 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 59 | Section 02, Tammy Romo 2026-05-27 | Form 4 | 2026-05-28 | 0001193125-26-245807 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 60 | Section 02, James L. Bierman 2026-05-27 | Form 4 | 2026-05-28 | 0001193125-26-245808 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 61 | Section 02, J. Robert Kerrey 2026-05-27 | Form 4 | 2026-05-28 | 0001193125-26-245805 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 62 | Section 02, Christopher S. Lynch 2026-05-27 | Form 4 | 2026-05-28 | 0001193125-26-245806 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 63 | Section 02, Nadja Y. West 2026-05-27 | Form 4 | 2026-05-28 | 0001193125-26-245811 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 64 | Section 02, Meghan M. FitzGerald 2026-05-27 | Form 4 | 2026-05-28 | 0001193125-26-245804 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 65 | Section 02, Nadja Y. West 2026-05-27 | Form 4 | 2026-05-28 | 0001193125-26-245811 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 66 | Section 02, Roy Blunt 2026-05-27 | Form 4 | 2026-05-28 | 0001193125-26-245813 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 67 | Section 02, J. Robert Kerrey 2026-05-28 | Form 4 | 2026-05-29 | 0001193125-26-249167 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 68 | Section 02, J. Robert Kerrey 2026-05-28 | Form 4 | 2026-05-29 | 0001193125-26-249167 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 69 | Section 02, J. Robert Kerrey 2026-05-28 | Form 4 | 2026-05-29 | 0001193125-26-249167 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 70 | Section 02, J. Robert Kerrey 2026-05-28 | Form 4 | 2026-05-29 | 0001193125-26-249167 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 71 | Section 02, J. Robert Kerrey 2026-05-28 | Form 4 | 2026-05-29 | 0001193125-26-249167 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 72 | Section 02, James L. Bierman 2026-07-27 | Form 4 | 2026-07-28 | 0001193125-26-321680 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 73 | Section 02, Paola Arbour 2026-07-27 | Form 4 | 2026-07-28 | 0001193125-26-321681 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 74 | Section 02, Christopher S. Lynch 2026-07-27 | Form 4 | 2026-07-28 | 0001193125-26-321682 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 75 | Section 02, Lisa Foo 2026-07-29 | Form 4 | 2026-07-31 | 0001193125-26-329146 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 76 | Section 06, 2026 vote | Form 8-K | 2026-05-29 | 0000070318-26-000028 | Item 5.07 · say-on-pay result. As reported: 84.11% (votes for as printed: 62,554,346). Filing ↗ |
| 77 | Section 06, 2025 vote | Form 8-K | 2025-05-27 | 0000070318-25-000020 | Item 5.07 · say-on-pay result. As reported: 93.15% (votes for as printed: 72,929,010). Filing ↗ |
| 78 | Section 06, 2024 vote | Form 8-K | 2024-05-23 | 0000070318-24-000034 | Item 5.07 · say-on-pay result. As reported: 96.4% (votes for as printed: 78,324,154). Filing ↗ |
| 79 | Section 03b vehicle mix (computed) | Computed | — | computed | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 80 | Section 09b board cost (computed) | Computed | — | computed | Cash 2,033,500 + equity 2,886,531 + all other 25,000 = 4,945,031, summed across the director compensation table rows.machine: formula: Σ = 4,945,031 |
| 81 | Tenet HealthCare (subject), Section 10b CEO total | DEF 14A | 2026-04-16 | 0001193125-26-159118 | CEO total compensation as printed in Tenet HealthCare's own proxy. As printed: 43,108,969. Filing ↗machine: r4 · c34 · span 969343–969353 |
| 82 | Baxter International, Section 10b CEO total | DEF 14A | 2026-03-23 | 0001628280-26-020330 | CEO total compensation as printed in Baxter International's own proxy. As printed: 29,805,182. Filing ↗machine: r4 · c30 · span 1451066–1451076 |
| 83 | HCA Healthcare, Section 10b CEO total | DEF 14A | 2026-03-13 | 0001193125-26-106142 | CEO total compensation as printed in HCA Healthcare's own proxy. As printed: 26,456,606. Filing ↗machine: span 784078–784088 |
| 84 | Stryker, Section 10b CEO total | DEF 14A | 2026-03-23 | 0000310764-26-000013 | CEO total compensation as printed in Stryker's own proxy. As printed: 21,401,495. Filing ↗machine: t101 · r2 · c7 · span 1584979–1584989 |
| 85 | Humana, Section 10b CEO total | DEF 14A | 2026-03-06 | 0001104659-26-024799 | CEO total compensation as printed in Humana's own proxy. As printed: 18,757,075. Filing ↗machine: t157 · r1 · c63 · span 1938706–1938716 |
| 86 | DaVita, Section 10b CEO total | DEF 14A | 2026-04-22 | 0000927066-26-000053 | CEO total compensation as printed in DaVita's own proxy. As printed: 18,210,597. Filing ↗machine: r2 · c45 · span 800715–800725 |
| 87 | Becton, Dickinson and Company, Section 10b CEO total | DEF 14A | 2025-12-18 | 0001628280-25-057846 | CEO total compensation as printed in Becton, Dickinson and Company's own proxy. As printed: 17,129,140. Filing ↗machine: r2 · c27 · span 1173285–1173295 |
| 88 | Universal Health Services, Section 10b CEO total | DEF 14A | 2026-04-09 | 0001193125-26-148814 | CEO total compensation as printed in Universal Health Services's own proxy. As printed: 16,148,937. Filing ↗machine: span 1326856–1326866 |
| 89 | Section 10a, Baxter International reciprocity | DEF 14A | — | 0001628280-26-020330 | Baxter International's most recent proxy was read; its disclosed peer group does not include Tenet HealthCare. Filing ↗ |
| 90 | Section 10a, HCA Healthcare reciprocity | DEF 14A | — | 0001193125-26-106142 | HCA Healthcare names Tenet HealthCare in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 91 | Section 10a, Stryker reciprocity | DEF 14A | — | 0000310764-26-000013 | Stryker's most recent proxy was read; its disclosed peer group does not include Tenet HealthCare. Filing ↗ |
| 92 | Section 10a, Humana reciprocity | DEF 14A | — | 0001104659-26-024799 | Humana's most recent proxy was read; its disclosed peer group does not include Tenet HealthCare. Filing ↗ |
| 93 | Section 10a, DaVita reciprocity | DEF 14A | — | 0000927066-26-000053 | DaVita names Tenet HealthCare in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 94 | Section 10a, Becton, Dickinson and Company reciprocity | DEF 14A | — | 0001628280-25-057846 | Becton, Dickinson and Company's most recent proxy was read; its disclosed peer group does not include Tenet HealthCare. Filing ↗ |
| 95 | Section 10a, Universal Health Services reciprocity | DEF 14A | — | 0001193125-26-148814 | Universal Health Services names Tenet HealthCare in its own disclosed peer group (read from its most recent proxy). Filing ↗ |